Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPLACIZUMAB-YHDP vs CAPTOPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPLACIZUMAB-YHDP vs CAPTOPRIL: Safety Overview

Metric CAPLACIZUMAB-YHDP CAPTOPRIL
Total FAERS Reports 1,397 1,126
Deaths Reported 59 108
Death Rate 4.2% 9.6%
Hospitalizations 270 615
Average Patient Age 46.1 yrs 56.1 yrs
% Female Patients 70.4% 60.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Bryant Ranch Prepack
Route N/A ORAL
Marketing Status Prescription Discontinued